Wednesday, March 15, 2023 11:57:06 AM
first there is talk about. Electromedical surrounding. Magic mushrooms....
So the intelligent among us. Rules out recreational magic mushrooms and starts looking at the opportunity. The opportunity in the medical area.
Then we see. An acquisition of AVAIL labs.
Next we see. A PR. About $6 million. Revenue potential in South Florida from the. CEO of a male labs.
Then we see a $25 million line of credit for the. Purchase. Of these electromedical devices, which will allow experts to read the neural pathways in. Suicidal. Veterans. In people who are addicted to heroin, in alcoholics, et cetera,
I am beginning to see. On the wall.
The future for Magic mushrooms. I would say Silocybin, if I could spell it easily.
The future is in medicine, not in recreation. Make note of that. Everybody.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM